CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population. - Wikidata - awgldk - TriplyDB

CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population.

CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population.

http://www.wikidata.org/entity/Q34552473

about

MTRR rs326119 polymorphism is associated with plasma concentrations of homocysteine and cobalamin, but not with congenital heart disease or coronary atherosclerosis in Brazilian patients.LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure.SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia.Gender-related associations of genetic polymorphisms of α-adrenergic receptors, endothelial nitric oxide synthase and bradykinin B2 receptor with treadmill exercise test responses.CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy Association between ABCB1 C3435T polymorphism and breast cancer risk: a Moroccan case-control study and meta-analysis.MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian population BDKRB2 +9/-9 polymorphism is associated with higher risk for diabetes mellitus in the Brazilian general population.A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation.Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.Minimum information required for a DMET experiment reporting.Type of LDLR mutation and the pharmacogenetics of familial hypercholesterolemia treatment.Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.Distribution of CYP2C19*2 and CYP2C19*3 polymorphisms in Venezuelan populations with different admixture.The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder.Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration.Genotyping of CYP2C19 polymorphisms and its clinical validation in the ethnic Arab population.A randomized controlled trial to assess the efficacy and safety of doubling dose clopidogrel versus ticagrelor for the treatment of acute coronary syndrome in patients with CYP2C19*2 homozygotes.CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population.Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study.Association of the C3435T polymorphism of the MDR1 gene and therapeutic doses of warfarin in thrombophilic patients.Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study.Associations between the functional polymorphisms in the ABCB1 transporter gene and colorectal cancer risk: a case-control study in Turkish population.Prevalence and significance of CYP2C19*2 and CYP2C19*17 alleles in a New Zealand acute coronary syndrome population.CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation.Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population.CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia.Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients.Pharmacogenomics, ancestry and clinical decision making for global populations Distribution of CYP2C Polymorphisms in an Amerindian Population of Brazil

P2860

Q33753471-9020178F-D981-4C8E-B438-57EEF1B14D77 Q33939240-20304908-9796-4D21-B69F-A8FE0315BEB3 Q33962753-82DF821E-AD82-496E-B826-B906A354E42A Q34047278-7A23E1CE-E8F0-4268-A4B6-B45FFA101A5F Q34387744-BC99A775-3941-4264-BD69-6A93BBB4B3B8 Q34768336-C38BAF90-97B8-4D10-B723-60DC2C1FA338 Q35129192-FD6FDCA1-0E2C-4EFB-8AD2-1D61B62802BE Q36118702-F1B8856D-DC83-4DF0-8D8A-044C39E674A9 Q36226649-4B8AF902-E56C-4497-9908-367013F2FC38 Q36454903-1E79383B-239A-451A-8731-79550F32E003 Q37207789-BB30E34C-881B-4859-A794-6E8712D2B6B8 Q37605071-63FED5E5-8974-4BAD-88C6-B8D8AEFB6FA5 Q37715233-99A28555-3FF3-463E-BB8E-B785D5CE6920 Q38407994-3B0808D2-3061-4ABE-98A1-E0F77A215C51 Q38596963-E05C9953-D474-43A0-8C86-53008FC7C5CD Q38616806-83660B51-2DDE-4DD9-AD5D-1744794DF7DB Q39501603-2DB7C31E-B8C4-4D27-9A11-BB57224051B7 Q40569531-68AAA6B6-ECFB-428C-9604-9A6133528EE2 Q40862073-823C84E7-D029-4315-8DB5-851DEB224BE8 Q41432957-1997840B-5E5C-4FB0-AF8F-60436FBC2396 Q41895739-7AC13236-A8D1-40E1-B305-3C97647D3F30 Q42315488-809E373E-7747-4EE2-8BDC-42CEA7F872B4 Q42703883-64EFC1D9-779E-40C0-9688-8FCCFBF3ADDE Q42728674-F1E1C3C4-A900-425A-8317-282AF5684BFA Q44502093-B3CE4099-A7AA-4021-9496-F955706C923D Q44760870-29017CC3-3898-49C6-8A05-03CA6FFAAF36 Q45821186-F556FE33-F0B2-4AAD-A7A1-BB005C65D258 Q47763354-2F0DF267-D266-4461-89CE-4FE154612975 Q53123523-2F669E9D-1ACB-4535-A170-F38A2E6343A8 Q53833189-51A0E225-DAA4-42CC-9E70-33D8E0F5DF69 Q54260617-F3F3889D-00C9-43D6-A994-6E9FB7C10D24 Q54559255-C9AF59FE-144E-4317-91FC-9BCE9BB1C4CD Q55039412-666E4EA5-DDF4-4B17-A891-785C022C95C3 Q55381224-EB6F1DA6-3E97-4FDB-A5AA-36336AEA6DC8 Q57278395-4AA40D27-58AA-4E7A-AD6F-3852A52715E5 Q57749415-6604392A-3B1D-4CC7-8E63-0311204F5089

P2860

CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population.

http://www.wikidata.org/entity/Q34552473

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

CYP2C19 and ABCB1 gene polymor ...... Brazilian general population.

@ast

CYP2C19 and ABCB1 gene polymor ...... Brazilian general population.

@en

CYP2C19 and ABCB1 gene polymor ...... Brazilian general population.

@nl

type

label

CYP2C19 and ABCB1 gene polymor ...... Brazilian general population.

@ast

CYP2C19 and ABCB1 gene polymor ...... Brazilian general population.

@en

CYP2C19 and ABCB1 gene polymor ...... Brazilian general population.

@nl

prefLabel

CYP2C19 and ABCB1 gene polymor ...... Brazilian general population.

@ast

CYP2C19 and ABCB1 gene polymor ...... Brazilian general population.

@en

CYP2C19 and ABCB1 gene polymor ...... Brazilian general population.

@nl

P1433

Q34552473-DEA372B2-4AEB-409A-B211-8CFFA828306B

P1476

Q34552473-9665559C-3769-4E29-B314-4EC2F7D0405A

P2093

Q34552473-557A4357-A55E-45D8-B728-96FE9B211AC1

Q34552473-558C2BFB-F326-43AB-BFAE-31BD7E1FFCF6

Q34552473-629896F2-7A64-4FBC-A1E0-444C179A1160

Q34552473-8E1C9EA2-F1DB-404D-8FF7-F46287F7E672

Q34552473-B28118E6-6B07-41FC-A4EA-E52B9CDE7F47

Q34552473-B7E10314-3B9B-450E-8BEA-96213FCE5F8C

Q34552473-D1F62A27-477D-4B7E-ADEB-4F91F0CAAC4D

Q34552473-ECD543DB-341E-4592-A7B5-1382AA334871

Q34552473-F89A7B2E-CC46-446E-A3A7-D46D26CBE137

P2860

Q34552473-0A77D5B6-FDA3-4988-BA7A-998D3C409DB5

Q34552473-0B1C7055-E540-4F2E-8746-7D0F012D771C

Q34552473-1FFFB5B4-833C-4CC8-A587-0BCBF4B6AE9D

Q34552473-292460CC-FB38-4E6C-9E10-BB66D3F7537D

Q34552473-2D52ACE5-92BE-4C23-AC54-1636924A6D04

Q34552473-3E73B433-C461-4F4A-8628-7ABDE096F5E9

Q34552473-405D6850-AC75-4553-8D54-1E94A268E22C

Q34552473-41825830-D7F3-4835-98C2-DAD16C1ECB03

Q34552473-46036CBA-03C3-4A45-9631-4C6D585059EB

Q34552473-518D3106-7320-44FE-B7C5-CB375A1CB031

P2888

Q34552473-5602E581-6AC4-447E-9ABE-0083C0D47F36

P304

Q34552473-CFC19B07-A547-4E7C-A16A-E6EF203CD76C

P31

Q34552473-A95D6453-3596-4DF0-A582-F848D6E6CC5F

P356

Q34552473-4AB690BD-9F6D-4BBC-A120-34366D124654

P478

Q34552473-062B9613-C827-4703-88F6-D80A8DB268E4

P577

Q34552473-92C742A0-ABF1-4AFD-AF1F-E39438D225E4

P5875

Q34552473-57C69FA0-93C4-4F67-8363-8DE832EA84A4

P6179

Q34552473-FF950CE8-9224-4D92-8F41-973BF4346AA5

P698

Q34552473-7BA99D8D-C023-4DE0-A768-65673291FAF7

P932

Q34552473-4BCCC653-19D4-49DF-9122-F92FC5D1BD38

P356

1471-2350-12-13

P1433

BMC Medical Genetics

P1476

CYP2C19 and ABCB1 gene polymor ...... Brazilian general population.

@en

P2093

Alexandre C Pereira

http://www.w3.org/2001/XMLSchema#string

Diogo B G Santos

http://www.w3.org/2001/XMLSchema#string

George L L M Coelho

http://www.w3.org/2001/XMLSchema#string

José C Nicolau

http://www.w3.org/2001/XMLSchema#string

José E Krieger

http://www.w3.org/2001/XMLSchema#string

José G Mill

http://www.w3.org/2001/XMLSchema#string

Paulo C J L Santos

http://www.w3.org/2001/XMLSchema#string

Raimundo M Nascimento

http://www.w3.org/2001/XMLSchema#string

Renata A G Soares

http://www.w3.org/2001/XMLSchema#string

P2860

A simple salting out procedure for extracting DNA from human nucleated cells

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.

CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation.

Nuclear Factor (NF) kappaB polymorphism is associated with heart function in patients with heart failure.

APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population.

Genetic determinants of response to clopidogrel and cardiovascular events.

Cytochrome p-450 polymorphisms and response to clopidogrel.

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study.

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

P2888

1471-2350-12-13

P304

13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2350-12-13

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49767316

http://www.w3.org/2001/XMLSchema#string

P6179

1015045326

http://www.w3.org/2001/XMLSchema#string

P698

21247447

http://www.w3.org/2001/XMLSchema#string

P932

3033793

http://www.w3.org/2001/XMLSchema#string